Skip to main content

Table 2 Comparison of clinicopathologic characteristics between HCC patients who experienced hepatic insufficiency or not after right hemi-hepatectomy

From: Safe standard remnant liver volume after hepatectomy in HCC patients in different stages of hepatic fibrosis

Characteristic

Insufficiency (n = 30)

No insufficiency (n = 55)

χ2 (t test)

P

Sex

    

 Male

28

42

3.846

0.05

 Female

2

13

  

HBsAg

    

 Positive

20

36

0.013

0.91

 Negative

10

19

  

Tumour number

    

 Single

18

34

0.027

0.869

 Multiple

12

21

  

Preoperative parameter

Age (year)

43.47 ± 9.09

45.38 ± 12.67

0.731

0.467

Platelet count (109/L)

243.08 ± 95.26

271.44 ± 79.10

1.390

0.171

Total bilirubin (μmol/l)

16.51 ± 6.88

14.97 ± 13.89

− 0.686

0.495

Albumin (g/L)

39.62 ± 4.93

38.74 ± 4.26

− 0.824

0.414

ALT (IU/L)

49.27 ± 24.15

43.49 ± 27.08

− 1.009

0.317

AST (IU/L)

94.43 ± 84.22

69.29 ± 44.26

− 1.808

0.074

Prothrombin time (s)

13.33 ± 1.25

12.61 ± 1.11

− 2.612

0.012*

Alpha-foetoprotein (μg/ml)

821.73 ± 516.56

742.67 ± 1267.02

− 0.405

0.686

Body surface area (m2)

1.99 ± 0.15

1.93 ± 0.17

− 1.465

0.148

Tumour size (cm)

12.10 ± 2.79

10.98 ± 4.06

− 1.499

0.138

Remnant liver volume (ml)

489.89 ± 177.39

586.16 ± 226.31

2.164

0.034*

SRLV (ml/m2)

238.25 ± 62.14

305.85 ± 103.35

3.762

0.000**

Child–Pugh classification

    

 A

22

49

2.452

0.117

 B

8

6

  

Intraoperative parameter

Blood loss (ml)

753.33 ± 623.52

687.27 ± 667.72

− 0.455

0.651

Postoperative parameter

Tumour capsule

    

 Yes

25

49

0.174

0.676

 No

5

6

  

Macrovascular invasion

    

 Yes

26

39

2.679

0.102

 No

4

16

  

Hepatic fibrosis stage

  

6.863

0.032*

 No significant fibrosis

7

24

  

 Severe fibrosis

7

17

  

 Cirrhosis

16

14

  

Hospital stay (days)

27.37 ± 7.78

25.51 ± 5.39

− 1.785

0.069

  1. Values are n (%) or mean ± SD, unless otherwise noted, *p < 0.05, **p < 0.01
  2. HBsAg hepatitis B surface antigen, ALT alanine transaminase, AST aspartate aminotransferase, BSA body surface area, SRLV standard remnant liver volume